European Journal of Radiology
Volume 75, Issue 1 , Pages 23-27 , July 2010

Radiofrequency ablation of pulmonary tumors

  • Laura Crocetti

      Affiliations

    • Corresponding Author InformationCorresponding author at: Division of Diagnostic Imaging and Intervention, Department of Liver Transplants, Hepatology and Infectious Diseases, Pisa University School of Medicine, Cisanello Hospital, Building No. 29, Via Paradisa 2, IT-56124 Pisa, Italy. Tel.: +39 050 996562; fax: +39 050 996561.
    • ,
  • Riccardo Lencioni

Received 25 March 2010 ,Accepted 31 March 2010.

References 

  1. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236
  2. Crocetti L, DeBaere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol. 2010;33:11–17
  3. Lencioni R, Crocetti L, Pina MC, et al. Percutaneous image-guided radiofrequency ablation of liver tumors. Abdom Imaging. 2009;34:547–556
  4. Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9:621–628
  5. Yamakado K, Inoue Y, Takao M, et al. Long-term results of radiofrequency ablation in colorectal lung metastases: single center experience. Oncol Rep. 2009;22:885–891
  6. Lanuti M, Sharma A, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009;137:160–166
  7. D’Addario G, Felip E ESMO Guidelines Working Group. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008;19 Suppl. 2:ii39–ii40
  8. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K. American College of Chest Physicians. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:234S–242S
  9. Raz DJ, Zell JA, Ou SH, et al. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest. 2007;132:193–199
  10. McGarry RC, Song G, des Rosiers P, Timmerman R. Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest. 2002;121:1155–1158
  11. Wisnivesky JP, Bonomi M, Henschke C, et al. Radiation therapy for the treatment of unresected stage I–II non-small cell lung cancer. Chest. 2005;128:1461–1467
  12. Qiao X, Tullgren O, Lax I, et al. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer. 2003;41:1–11
  13. Fernando HC, Hoyos AD, Litle V, Belani CP, Luketich JD. Radiofrequency ablation: identification of the ideal patient. Clin Lung Cancer. 2004;6:149–153
  14. McCormack PM, Ginsberg RJ. Current management of colorectal metastases to the lung. Chest Surg Clin North Am. 1998;8:119–126
  15. Weiser MR, Downey RJ, Leung DH, Brennan MF. Repeat resection of pulmonary metastases on patients with soft tissue sarcoma. J Am Coll Surg. 2000;191:184–190
  16. Shu Yan Huo A, Lawson Morris D, King J, Glenn D. Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma. Ann Surg Oncol. 2009;16:3169–3175
  17. Nakamura T, Matsumine A, Yamakado K, et al. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas. Cancer. 2009;115:3774–3781
  18. Hiraki T, Gobara H, Mimura H, et al. Does tumor type affect local control by radiofrequency ablation in the lungs?. Eur J Radiol. 2010;74:136–141
  19. de Baère T, Palussière J, Aupérin A, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006;240:587–596
  20. Ambrogi MC, Fanucchi O, Lencioni R, Cioni R, Mussi A. Pulmonary radiofrequency ablation in a single lung patient. Thorax. 2006;61:828–829
  21. Iguchi T, Hiraki T, Gobara H, et al. Percutaneous radiofrequency ablation of lung tumors close to the heart or aorta: evaluation of safety and effectiveness. J Vasc Interv Radiol. 2007;18:733–740
  22. Fernando HC. Radiofrequency ablation to treat non-small cell lung cancer and pulmonary metastases. Ann Thorac Surg. 2008;85:S780–S784
  23. Van Cutsem EJ, Oliveira J ESMO Guidelines Working Group. Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008;19 Suppl. 2:ii33–ii34
  24. Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology. 2006;241:275–283
  25. Yasui K, Kanazawa S, Sano Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology. 2004;231:850–857
  26. Sano Y, Kanazawa S, Gobara H, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer. 2007;109:1397–1405
  27. YamagamiT , KatoT , HirotaT , et al. Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms. J Vasc Interv Radiol. 2006;17:1625–1629
  28. Gillams AR, Lees WR. Analysis of the factors associated with radiofrequency ablation-induced pneumothorax. Clin Radiol. 2007;62:639–644
  29. Hoffmann RT, Jakobs TF, Lubienski A, et al. Percutaneous radiofrequency ablation of pulmonary tumors. Is there a difference between treatment under general anaesthesia and under conscious sedation?. Eur J Radiol. 2006;59:168–174
  30. Lencioni R, Crocetti L, Cioni R, et al. Radiofrequency ablation of lung malignancies: where do we stand?. Cardiovasc Intervent Radiol. 2004;27:581–590
  31. Crocetti L, Lencioni R, Bozzi E, Sbrana A, Bartolozzi C. Lung radiofrequency ablation: in vivo experimental study with low-perfusion-rate multitined electrodes. Cardiovasc Intervent Radiol. 2008;31:610–618
  32. Anderson EM, Lees WR, Gillams AR. Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Intervent Radiol. 2009;32:478–483
  33. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205–216
  34. Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg. 2005;129:639–644
  35. Beland MD, Wasser EJ, Mayo-Smith WW, Dupuy DE. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology. 2010;254:301–307
  36. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007;243:268–275
  37. Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology. 2004;230:125–134
  38. Pennathur A, Luketich JD, Abbas g , et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg. 2007;134:857–864
  39. Hiraki T, Sakurai J, Tsuda T, et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors. Cancer. 2006;107:2873–2880
  40. Dupuy DE, DiPetrillo T, Gandhi S, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest. 2006;129:738–745
  41. Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol. 2006;17:1117–1124
  42. Yan TD, King J, Sjarif A, Glenn D, Steinke K, Morris DL. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol. 2006;13:1529–1537
  43. Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol. 2007;18:393–398
  44. Hiraki T, Gobara H, Iishi T, et al. Percutaneous radiofrequency ablation for pulmonary metastases from colorectal cancer: midterm results in 27 patients. J Vasc Interv Radiol. 2007;18:1264–1269
  45. Pfannschmidt J, Muley T, Hoffmann H, Dienemann H. Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg. 2003;126:732–739
  46. Saito Y, Omiya H, Kohno K, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg. 2002;124:1007–1013
  47. McCormack PM, Bains MS, Begg CB, et al. Role of videoassisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. Ann Thorac Surg. 1996;62:213–216
  48. Mutsaerts EL, Zoetmulder FA, Meijer S, Baas P, Hart AA, Rutgers EJ. Long-term survival of thoracoscopic metastasectomy vs metastasectomy by thoracotomy in patients with a solitary pulmonary lesion. Eur J Surg Oncol. 2002;28:864–868
  49. Steinke K, Sewell PE, Dupuy D, et al. Pulmonary radiofrequency ablation—an international study survey. Anticancer Res. 2004;24:339–343
  50. Okuma T, Matsuoka T, Yamamoto A, et al. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Intervent Radiol. 2008;31:122–130
  51. Covey AM, Gandhi R, Brody LA, et al. Factors associated with pneumothorax and pneumothorax requiring treatment after percutaneous lung biopsy in 443 consecutive patients. J Vasc Interv Radiol. 2004;15:479–483
  52. Hiraki T, Mimura H, Gobara H, et al. Two cases of needle-tract seeding after percutaneous<radiofrequency ablation for lung cancer. J Vasc Interv Radiol. 2009;20:415–418
  53. Yamakado K, Akeboshi M, Nakatsuka A, et al. Tumor seeding following lung radiofrequency ablation: a case report. Cardiovasc Intervent Radiol. 2005;28:530–532

PII: S0720-048X(10)00175-0

doi: 10.1016/j.ejrad.2010.04.011

European Journal of Radiology
Volume 75, Issue 1 , Pages 23-27 , July 2010

Article Tools